Skip to content
FIND A HEALTH VALLEY ACTOR

News

If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Latest BioAlps news

On this page you will find all the latest news regarding BioAlps affiliated members and life sciences activities in western Switzerland.

All the latest press articles featuring BioAlps can be found in our Media Center on our About page.

Addex-neurosterix

Addex and Perceptive launch Neurosterix with USD 63 Million investment

Geneva-based Addex Therapeutics and funds affiliated with Perceptive Advisors, an investment management firm focused on the life sciences sector, today…

Voluminia Medical

Volumina Medical secures USD 21 Million Funding

Volumina Medical, a clinical stage MedTech company developing novel biomaterials for dermatology and plastic surgery, announces the successful closing of…

Venture leaders - biotech 24

Venture Leaders Biotech unveils its 2024 cohort for the Boston roadshow

The Swiss National Startup Team has selected its 10 startups for the Venture Leaders Biotech 2024. The entrepreneurs will meet…

UNIGE-cystic fibrosis

Cystic fibrosis: why infections persist despite therapy

A UNIGE team discovered that treatment for cystic fibrosis does not eliminate the docking stations of bacteria responsible for respiratory…

Katzarov-patent-trademarks

The crucial role of trademark and patent registration for startups

With more than 50 years’ experience, Katzarov advise companies and entrepreneurs on all matters related to intellectual property (IP). Thanks…

EPFL Anna Fontcuberta

Anna Fontcuberta i Morral to be the next EPFL president

Professor Fontcuberta i Morral will be the first woman to lead a Swiss Federal Institute of Technology since they were…

EPFL-single-neurons

EPFL is locating single neurons that monitor and regulate the heart and lungs

EPFL neuroscientists have located single neurons in a deep structure of the brain that regulates the heart and the lungs,…

e-health-eu-project

The Institute of Informatics to lead an European project

The Institute of informatic’s eHealth research cluster has been awarded scientific coordination of the European Hereditary project.     The…

Spineart-baguera

Spineart successfully raised a CHF20 Million convertible financing

Spineart secures more than CHF 20 Million in convertible financing following completion of BAGUERA® C IDE studies enrolment.    …

GGBa report 2023

GGBA 2023 report confirms Western Switzerland’s appeal to foreign companies

17 foreign companies have joined the Swiss Health Valley in 2023, with the prospect of creating more than 150 jobs…

Lonza expansion US

Lonza acquires a new manufacturing site in the US

Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, announced the signing of an agreement to acquire…

ERC grants

Researchers based in Switzerland can once again apply for ERC grants

As negotiations between the EU and Switzerland have been officially launched today, researchers based in Switzerland can now once again…

Alithea-seed-extension

Alithea Genomics closes CHF 2.8 Million in seed financing extension

This milestone marks a significant step forward in the company’s journey to revolutionise large-scale RNA sequencing and transcriptomics.    …

Perivision-us fda

PeriVision announces FDA registration for its medical software VisionOne™

PeriVision, proudly announces its recent FDA registration for its first medical software product VisionOne.     This significant milestone marks…

Pristem-radiology-center

Pristem affordable radiology thrives in South Africa

A few months ago, Pristem’s South African subsidiary opened its first state-of-the-art, affordable radiology center in the township of Alexandra….

IOnctura-FDA

US FDA grants Orphan Drug Designation for iOnctura’s Autotaxin cancer therapy

iOnctura’s autotaxin inhibitor cambritaxestat for the treatment of pancreatic cancer gets Orphan Drug Designation (ODD) by the US FDA.  …

Debiopharm-wee1

Debiopharm launches expansion of WEE1 inhibitor

Debiopharm aims to further characterise the safety, tolerability, and preliminary anti-tumour activity of its potent WEE1 inhibitor Debio 0123 as…

abcd x-andalusian-hospital

Collaboration between ABCDx and Andalusian Hospitals

ABCDx is collaborating with Andalusian hospitals to improve stroke triage inside ambulances.     Thanks to a public-private grant from…

International women days

Six women-centred initiatives you should know about

From successful entrepreneurs to academics and industry leaders, the Swiss Health Valley is full of inspirational women working in life…

HUG-RLT

A multidisciplinary HUG team launches a new study of innovative radioligand therapy (RLT)

A new radioligand to treat glioblastoma and digestive tumors evaluated as a world first at the Geneva University Hospitals (HUG)….

Terapet receives EUR 1.68 Million Eurostars grant

Terapet announced the receipt of a non-dilutive grant totalling approximately EUR 1.68 Million from the European Commission through the Eurostars…

FIT-artiria-planny-algorized

Artiria Medical, Planny and Algorized receive support from FIT

The three startups have received financial support from the Foundation for technological innovation (FIT). Artiria Medical gets a Tech Growth…

Dopamine

Dopamine production is not behind vulnerability to cocaine abuse

A UNIGE team shows that our ability to produce dopamine – the «happiness hormone» – is not correlated with increased…

Agora Care celebrates 10’000 patients and a new collaboration with Caduceo

The Campus biotech startup, recruited over 10’000 patients on its Agora Care platform.     This marks an inflection point…

FONGIT FIF

FONGIT Innovation Fund (FIF) awards funding to Geneva-based tech projects

A seed loan of CHF 100,000 has been granted to previous FIF Grant laureate and HUG spinoff HeroSupport. One grant…

Artiria Medical

Artiria Medical successfully secures USD 6 Million

Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the Us, following promising first…

Leenaards prize

Leenaards Prize awarded to two CHUV research groups

The two Leenards scientific prizes were awarded to research groups led by CHUV researchers.     Each year, the Leenards…

New Biologix - licensing

NewBiologix announced a licensing agreement with Florabio AS

NewBiologix SA announced a licensing agreement with Florabio AS to genetically engineer their proprietary HEK293 cell line.     NewBiologix’s…

Aktiaa secures 27M

Aktiia secures CHF 27 Million

The Neuchâtel-based startup secures CHF 27 Million (USD 30M) in funding from Khosla Ventures and Others.     Aktiia mission…

Future of health march 204

Future of Health Grant unveils its March 2024 cohort

Startups Resilient SA and Maven Health are among the eight new startups selected by the Future of Health Grant (FoHG)…

ArgaMedtech-series b

Argá Medtech SA closes oversubscribed Series B

Argá Medtech announces €54 Million oversubscribed series B capital raise.     The round was led by the existing investors,…

Prix strategis

Two life sciences startups shortlisted for the 31st Prix Strategis

Testmate Health and Seprify are among the eight semi-finalists of this year’s Prix Strategis.     Every year for almost…

Albionic-Patrick pestalozzi

Abionic appoints Patrick Pestalozzi as new CEO to propel company into next growth phase

Abionic SA, a Swiss leader in nanofluidic point-of-care diagnostic solutions, announced the appointment of Patrick Pestalozzi as its new CEO,…

CSEM bioreactor

CSEM and ClexBio create a bioreactor to manufacture tissue-engineered cardiovascular implants

A new type of bioreactor that can grow human veins in the lab has been developed by CSEM and ClexBio,…

Biopole review 2023

The Biopôle Review – 2023 edition

Check out all the key figures from Biopôle’s community, inspiring interviews and more in their latest review.     Biopôle,…

Atinary-takeda-partnership

Atinary and Takeda collaborate to drive innovation in healthcare

Atinary Technologies, a Vaud based startup, announced a strategic collaboration with Takeda, Japanese largest pharmaceutical company.     This partnership…

UNIGE-innovative materials-bacteria

Innovative materials to combat bacteria

A UNIGE team is developing new alloys with bactericidal properties to combat antibiotic-resistant germs.     While crucial to biotechnology,…

Alys Pharmaceuticals

Alys Pharmaceuticals launches with $100 Million financing from Medicxi

Formed through the aggregation of six-asset centric Medicxi companies, including Aldena Therapeutics, Alys boasts a robust R&D pipeline of cutting-edge…

Prof. Antoine Geissbuhler BioAlps President

“Bringing meaning back to the healthcare professionals”

Appointed Dean of the Faculty of Medicine at the University of Geneva, Professor Antoine Geissbuhler, is also Director of Teaching…

Multiwave technologies

Multiwave Technologies partners with Aix Marseille University

Multiwave Technologies brings to market a portable MRI device powered by metamaterial technologies and AI software. ​ The partnership includes joint research…

BioSpectal

Monitor your blood pressure with OptiBP, a Biospectal application

Patients can measure their blood pressure in 30 seconds by placing their fingertip on the camera lens of a smartphone….

BioLizard

BioLizard chooses Biopôle for its Swiss subsidiary

BioLizard is a Belgian bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life…

Oryl Photonics

Oryl Photonics raises CHF 830,000 in seed funding

The Vaud-based startup announces the successful conclusion of a CHF 830,000 seed fundraising. The round is backed by Swiss investors,…

CSEM Inventor Award

CSEM Inventor Award granted to spaceCoder

Shedding Light on Precision: CSEM spaceCoder technology is a game changer in the field of precision measurement     In…

GeNeuro

Successful € 5 Million Capital Increase for GeNeuro

GeNeuro, a Geneva-based biopharmaceutical company focusing on treatments for neurodegenerative and autoimmune diseases, including multiple sclerosis (MS), amyotrophic lateral sclerosis…

Nicolas Durand 2

Nicolas Durand appointed Director of the Campus Biotech Foundation in Geneva

Dr Nicolas Durand will step down from his CEO role at Abionic on 29 February to be at the steering…

Swiss Venture Capital Report

CHF 870 Million invested in Swiss medtech and biotech companies

In the midst of an unfavourable environment, the life sciences’ sector continues to attract investors in Switzerland according to the…

Debiopharm

Debiopharm and TransCode Therapeutics Collaborate to Develop Targeted Nucleic Acid Therapeutics for Cancer

TransCode Therapeutics is a RNA oncology company based in the United States committed to more effectively treating cancer using RNA…

InvestPro Programme Vaud

Vaud: a CHF 90 Million plan to tackle the shortage of healthcare staff

The Vaud State Council has drawn up a CHF 90 Million “far-reaching plan” to meet the challenges presented by the…

Transmutex

Transmutex raises CHF 20 Million

The Geneva-based company, founded in 2019, has secured new funding to further develop its research into safer, cleaner and cheaper…

Pfizer Foundation Prize

Pfizer Research Prize: 3 Researchers From The Swiss Health Valley Awarded

13 young researchers from Fribourg, Geneva, Basel, Bern, and Zurich have won a 2024 Pfizer Research Award.   Since 1992,…

Prof. Jabaudon

The Roger de Spoelberch Prize Awarded to a UNIGE Researcher

Professor Denis Jabaudon, Director of the Department of Basic Neuroscience and member of the Synapsy Center for Neuroscience Research in…

Lonza Visp

Lonza Achieves Strong Financial Results in 2023 Amid Leadership Transition

The Swiss CDMO announces robust sales of CHF 6.7 billion, delivering 10.9%1 CER sales growth, and the nomination of Jean-Marc…

Stämm

Stämm chooses Valais to set up its European team

The Argentinian biomanufacturing innovator is launching its R&D facility at the BioArk in Monthey     Founded in 2016 in…

PhenomX Health

PhenomX Health and Issviva launch a programme to help women manage Stress and Sleep during Menopause

In a pioneering partnership, Issviva Menopause and the Swiss startup PhenomX Health have united their expertise to empower women navigating…

LightHouse

The Lighthouse Partnership: a Swiss cooperation to propel AI-Guided Neuromodulation

This 4 years partnership is funded with CHF 18 Million from the Wyss Center, and involves EPFL Neuro X Institute,…

Fluosphera

FluoSphera is awarded a CHF 1.1 million grant from Innosuisse

FluoSphera S.A., a biotechnology company developing versatile and disruptive in-vitro solutions for drug discovery to predict drug efficacy and safety…

FIT - Jan 2024

Maven Health, NeoSens and NADUP supported by the FIT

Three life science projects have received support from the Foundation for Technological Innovation (FIT) in the form of Tech Grants:…

Novostia_implantation

First-in-Human implantation for Novostia’s heart valve

The Vaud-based startup, located at the Biopôle, successfully implanted its TRIFLO valve in a human.     Novostia, a pioneering…

Debiopharm-innovation-fund

Debiopharm Innovation Fund invests in MedaSystems

MedaSystems secures additional funding from Debiopharm Innovation Fund to accelerate global access to pre-approval treatment.     Medasystems, a pioneer…

FIT - Doopl and Rea

FIT loans CHF 500,000 to Doppl and CHF 100,000 to Rea Diagnostics

DOPPL, a leader in organoid engineering for disease modelling and personalised medicine, has received a Tech Growth loan of CHF…

Cellestia-innosuisse-grant-2

Cellestia secures a CHF 2 Million grant from Innosuisse

The Biopôle based startup was awarded an Innosuisse Grant to advance a groundbreaking Graft versus Host Disease prevention therapy.  …

Novartis - Calypso

Calypso enters into agreement to be acquired by Novartis

Calypso’s shareholders will receive an upfront payment of $250 Million upon closing and are eligible to receive up to $175…

Timeline

Timeline raises CHF56 Million and partners with L’Oréal

Already backed by Nestlé, the Swiss Health Valley startup co-founded by former EPFL President Patrick Aebischer, now counts a second…

Debiotech

Debiotech launches its engineering house

New year, new challenges! Debiotech, a leader in medical technologies based in Lausanne – Switzerland, announces the launch of its…

Tune Insight Team

Tune Insight leads a €1.8 Million project for data collaboration in paediatric emergency units

The EPFL spin-off has created a technology able to move past privacy and security issues for data sharing. The project,…

Stalicla SA

Stalicla Secures $17.4 Million in Series B Financing

The Geneva-based clinical-stage biopharmaceutical company is advancing precision medicine pipelines for neuropsychiatric and neurological disorders     STALICLA announces the…

The Sense Baby Study

Babies prefer human voices

The brains of 4-month-old babies respond preferentially to the human voice over sounds from their environment. This is confirmed by…

Kickfund Venture

Kickfund Ventures: CHF 70 Million for Swiss deeptech startups

The fund, backed by a diverse group of investors, including anchor investors Ernst Göhner Stiftung and Gebert Rüf Stiftung, will…

Socorex and CSEM

Socorex wins the CSEM Digital Health Journey Award

This SME based in Ecublens (VD), is a world leader in development and manufacture of high-end precision dosing instruments for…

Ferring

Ferring and PharmaBiome enter into a new microbiome R&D collaboration and exclusive licensing agreement

Collaboration leverages the proven development and commercial capability of Ferring with PharmaBiome’s compelling technology to research, develop and manufacture novel…

The Swiss HealthTech Center in Biel

Thanks to its location, diverse culture, extensive experience and infrastructure, Switzerland Innovation Park Biel/Bienne (SIPBB) is the perfect platform to…

Fongit Innovation Fund

4 life sciences projects supported by the FIF

Four Geneva-based technology projects have won funding from the Fongit Innovation Fund (FIF) for their innovations. A seed loan of…

ASPIVIX

ASPIVIX receives CE Mark approval for Carevix™

ASPIVIX, announced that carevix™, its novel Cervical Stabilizer, has attained CE marking. This next generation medtech device for routine procedures…

Gliapharm

Alzheimer Research: Gliapharm raises CHF 3.65 Million

The Alzheimer’s Drug Discovery Foundation (ADDF) invests CHF 3.64 Million in GliaPharm to advance its lead programme to accelerate the…

Aesyra

Aesyra raises CHF 2.6 Million

The Vaud-based and EPFL spin-off develops oral appliances preventing sleep bruxism and sleep apnea. The seed financing round was led…

Vandria

Vandria Announces a CHF 18 Million Fundraising

The $20.6M (CHF 18M) round was led by ND Capital together with a small syndicate of HNW private investors. The…

NEWS BIOPOLE

What all life sciences start-ups should know about fundraising

The Biopôle campus in Lausanne brings together some of the world’s most innovative life sciences companies. But how does an…

Haleon PVEI

Haleon awarded by the Prix Vaudois des Entreprises Internationales (PVEI)

Haleon, a former division of GSK that became independent in 2022, won the jury’s award in the “Foreign company” category….

Orio Therapeuthics

A CHF 40,000 Grant from Venture Kick to Orio Therapeuthics

Orio Therapeutics has won a CHF 40,000 Venture Kick prize, alongside KIDEMIS and Rheo, with a project designed to reduce…

AC Immune

Dr. Madiha Derouazi becomes AC Immune’s CSO

Dr. Madiha Derouazi is the founder of the Swiss biotech AMAL Therapeutics and the former CEO of German-based company Speransa…

Diatheris 1

A CHF 2.5 Million Grant for Diatheris

The Leona M. and Harry B. Helmsley Charitable Trust in the United States supports the Diatheris project, a UNIGE spin-off…

LLM EPFL

EPFL publishes a Large Language Model for medical knowledge

Researchers at EPFL’s Faculty of Computer Science and Communications have developed two large language models (LLMs) specialising in the healthcare…

Siegfried - Marcel Signer

Siegfried in Evionnaz: 150 years of pharmaceutical innovation

About fifty people from the Swiss Health Valley had the chance to visit the Siegfried production site in Evionnaz, during…

B Levrat HUG

Bertrand Levrat leaves the HUG

Bertrand Levrat, CEO of the University Hospitals of Geneva, joins Mediclinic, a private group   Bertrand Levrat, Chief Executive Officer…

Senbiosys Velia Smart Ring

Velia Smart Ring raises already CHF 1.5 Million

After raising CHF 622,672 on Kickstarter, Senbiosys launched another campaign on Indiegogo and already raised about CHF 1.5 Million for…

Digisanté

CHF 400 Million for Digisanté, a programme to transform the Swiss Healthcare system

The Swiss Federal Council wants to start Digisanté, a programme for the digital transformation of the healthcare system. The aim…

Biped.ai

Biped.ai raises CHF 1,2 Million

The EPFL spin-off created a harness acting as a copilot for visually-impaired people     “This funding round will help…

ProSeed

ProSeed wins a CHF 100,000 loan from FIT

Giving a second life to brewing by-products     ProSeed’s mission is to transform the Swiss food industry by upcycling…

Sitem Insel - DIC

A moving X-Ray Machine for research on joints and bones

Sitem-insel has inaugurated Europe’s inaugural Dynamic Imaging Center (DIC). This cutting-edge laboratory captures X-ray images of individuals in motion, presenting a…

Mara Graziani

Mara Graziani receives the prestigious Latsis Prize

Mara Graziani, research assistant at the HES-SO Valais-Wallis, has been awarded the prestigious Latsis prize worth CHF 25,000, which rewards…

FIF Nov 2023

TheraPPi Bioscience, MPC Therapeutics SA and dEEgtal awarded by the FIF

The Fongit Innovation Fund (FIF) has awarded three Geneva-based life sciences projects for their groundbreaking innovations.     A seed…

CSEM Insel Partnership

A new medtech hub in Bern

The Canton of Bern wants to establish itself as a leading international medical location by 2030. To achieve this, the…

Comphya

Comphya SA announce successful inaugural surgery for erectile dysfunction in Spinal Cord Injury Patients

The first implantation of CaverSTIM, the medical devices invented by Swiss company Comphya, in spinal cord injury individuals has been…

BioAlps Awards 2023

BioAlps Awards 2023

Dr. Hervé Bourlard receive the BioAlps Academia Award, and Dr. Igor Fish and Dr Nicolas Mermod receive the BioAlps Industry Award.

.Neurorestore

An implant to restore walking in Parkinson’s patients

Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL, Inserm and the University of Bordeaux have designed a neuroprosthesis to correct the gait disorders…

Novochizol SA

Cancer Research: CHF 1.1 Million for Novochizol SA

Cancer: EPFL and Novochizol SA to collaborate on designing more efficient immunotherapies, with the support of Innosuisse, the Swiss Innovation Agency.

Debiotech

DEBIOTECH, your local expert and partner for the development of medical devices

Debiotech is delighted to support catalysing innovation and advancing healthcare. The Swiss medtech company is proud to be part & contribute to BioAlps Networking Day 2023 on 9 November 2023 at Campus Biotech.

Mass Challenge Award 2023

Impossible Materials wins the Mass Challenge Diamond Prize

The University of Fribourg chemtech spin-off has been granted CHF 120,000 in cash. The start-up provides cellulose white pigment solutions…

HUG Award

HUG wins award for smarter medicine in intensive care

At the 46th World Hospital Congress organised by the International Hospital Federation (IHF), the University Hospitals of Geneva (HUG) received…

FIT Impact: 3 life sciences projects awarded

The first cohort to benefit from FIT Impact is now known. This programme run by the Foundation for Technological Innovation…

Abionic

LASCCO SA and Abionic SA announce a partnership to commercialize a sepsis diagnostic solution in China

LASCCO SA and Abionic SA, both based in Biopôle in Epalinges, announced that they have signed a licensing agreement with…

FONGIT - FIF Oct 2023

EarlySight SA and ArtemiX Biotech SA supported by the FIF

Two Geneva-based life sciences startups have been awarded the Fongit Innovation Fund (FIF) for their innovative projects. A seed loan has…

Debiopharm Valais

Debiopharm invests CHF 30 million in a life sciences building in Valais

This new facility will host some 2400 m2 of research laboratories, in Martigny where Debiopharm’s workforce jumped from 150 to…

HUG Innovation DAY 2023

HUG Innovation Day: A Pioneer Of New Therapies For Deafness Awarded

On the occasion of their 17th Innovation Day, held on 19 October, the Geneva University Hospitals (HUG), in partnership with…

Lagosta

Lagosta partners with Merck for the distribution of Chitosan

LAGOSTA S.A. announces that it has entered into a collaboration with the global science and technology company Merck for the…

Ibex™ Lonza facilit in Visp Switzerland

Lonza: 300 jobs in Visp for a new vaccine

Lonza’s Visp site is preparing to manufacture components of a vaccine to protect against pneumococcus. Hundreds of jobs are at…

Hedera Dx

Hedera Dx Launches Blood Based Cancer Testing

Hedera Dx, a Vaud-based oncology company specializing in liquid biopsy testing, has unveiled a fully streamlined solution that allows hospitals…

SOPHiA GENETICS

SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca

The three companies will collaborate to address global inequalities in comprehensive cancer care, and to improve global access to advanced…

Emovo Care

Emovo Care receives a CHF 100’000 FIT loan

The FIT (Fondation pour l’Innovation Technologique) in Canton of Vaud supports Emovo Care with a FIT Tech Seed loans of…

Limula BioTools Innovators

Limula wins the $250,000 BioTools Innovator Grand Prize

BioTools Innovator, a Los Angeles-based accelerator focused on life science tools companies, awarded Limula the grand prize of the BioTools…

CNS Therapy

CNS Therapy secures a CHF 1.1 Million investment

The Jura-based start-up, CNS Therapy, has raised a seed round funding totalling CHF 1 Million from private investors and CHF…

Smartcardia

SmartCardia received FDA clearance for its ECG monitoring patch and cloud platform

The EPFL-spin-off created the SmartCardia’s 7L patch, an easy-to-wear, cable-free, waterproof device that can be used for continuous monitoring for…

DayOne Tech

4 new Medtech Start-Ups join the DayOne Tech Accelerator in Canton of Jura

The DayOne Tech accelerator for medtech project is a pillar of the Jura’s medical technology economy. Four new start-ups joined…

Chuv Lymphoedema

Innovations at the CHUV in the treatment of lymphoedema

Swelling of one or more limbs as a result of lymphoedema – a common but little-understood condition – affects one…

Terapet + Korean

CHF 3 Million for Terapet and two South Korea partners

Terapet SA together with their South Korean partners Yonsei Cancer Center (Heavy Ion Therapy Center) and Oncosoft Inc. are awarded…

Mimix Biotherapeutics

A CHF multimillion investment for Mimix Biotherapeutics

Mimix Biotherapeutics in Biel (Bern) secures significant investment to translate and commercialize a new treatment technique for human tissue regeneration….

BioArk 3rd Building

BioArk Monthey: a 3rd building dedicated to life sciences and biotechnologies

BioArk is on a roll! The Monthey-based technology site, which is celebrating its 20th anniversary this year, inaugurated its third…

Lonza Visp

Lonza further expands in Visps thanks to a new partnership

A new agreement with an undisclosed global biopharmaceutical partner will quadruple current dedicated bioconjugation capacity by adding two new production…

Novostia

Novostia starts clinical trials of its new heart valve in Lituania

Novostia has received the green light from the Lithuanian State Health Care Accreditation Agency under the Ministry of Health to…

Medicrops

Medicrops acquires Swiss Alpinopharma

A strategic move to enhance digital patient care in the booming European cannabis market.     MediCrops Holding AG (‘MediCrops’),…

Aerium Therapeutics

Covid-19 Research: Aerium Therapeutics begins development of three in-licensed antibodies

Aerium Therapeutics, a company based in Lausanne and Boston, focuses on the development of antiviral therapeutics for COVID-19 and emerging…

Cancer Research: HES-SO Valais-Wallis and Debiopharm sign a partnership

The Life Technologies Institute of the Haute École d’Ingénierie has signed a new five-year collaboration agreement with Debiopharm Research &…

Professeur Nicolas Thomä

Cancer Research: ISREC Foundation and EPFL announce the creation of the Paternot Chair

The chair will be held by Professor Nicolas Thomä. The ISREC Foundation is contributing to the funding of the Chair…

HeroSupport

HeroSupport wins a CHF 150,000 Venture Kick Grant

The HUG and UNIGE spin-off wants to improve cancer treatment universal access with tailored patient-positioning medical devices and standardized workflows….

Tune Insight

Tune Insight raises CHF 3,1 Million

The round is led by 14Peaks Capital, with participation from investors including Inflection.xyz, Debiopharm Innovation Fund and Zurich Cantonal Bank….

Nagi Biocience

Nagi Bioscience secures CHF 12.4 Million Investment

Nagi Bioscience, a Swiss life sciences company developing next-generation laboratory equipment to unlock the full potential of alternatives to animal…

Debiopharm Innovation Fund

Debiopharm Innovation Fund: a new seed fund dedicated to Digital Health

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, announces the launch…

Atinary

Atinary Technologies raises CHF 4.6 Million

The Biopôle-based start-up has developed a machine learning platform dedicated to materials discovery. The seed-round was round led by AgFunder…

Future of Health Grant

Future Health Grant – 9 new projects selected

This great Swiss Health Valley🇨🇭 initiative was started by CSS and EPFL Innovation Park to promote Medicine 3.0. The 9…

Future Health Lausanne

Future Health Lausanne, an opportunity for the Swiss Health Valley

Future Health Lausanne is taking place on 3 October 2023 at the Swisstech Convention Center in Lausanne. The event is…

Adiposs

Adiposs SA announced the completion of the phase I clinical trial of its ImageBAT™

Adiposs SA, a Swiss biotech company developing medical imaging products and technologies, announced the completion of the phase I clinical…

ADDEX Therapeutics

A consortium led by Addex Therapeutics secures a €4 million Eurostars grant

The Geneva-based pharmaceutical company will use the grant to support its programme for mild neurocognitive disorders (mNCD).     The…

Multiwave technologies

Multiwave raises CHF 3.8 Million

Geneva-based deeptech startup Multiwave Technologies SA, led by Tryfon and Panos Antonakakis, is attracting new capital that will be dedicated…

Unige Cancer cells

Swiss Cancer Center Léman found a way to boost artificial immune cells to fight cancer

A team of Swiss researchers has discovered a way of prolonging the efficacy of CAR-T cells in immunotherapy for the…

Mecaplast Swiss - 4à6

A visit at Mecaplast Swiss

Over the decades, Mecaplast Swiss has extended its offering beyond plastic injection per-say. The company may collaborate as early as the design phase, up to shipping fully finished products to its clients across the globe. The new ISO 7 clean room strengthens the offer as it is mainly be dedicated to the post-injection operations, assembly, finishing and packaging to meet the fast-growing demand of the MedTech industry.

Ibex™ Lonza facilit in Visp Switzerland

Lonza to stop producing Moderna vaccine in Visp

Production of the Moderna serum will cease at Visp in the canton of Valais. In addition, Lonza’s Managing Director, Pierre-Alain…

Socorex - 60 years

Socorex, 60 years of success in precision volumetry

The story begins in 1963, in Canton of Vaud (Switzerland) with the know-how gathering of small companies active in manufacturing…

CUTISS AG

CUTISS AG launches its Series C funding round

CUTISS AG, a Swiss company specialising in regenerative skin medicine and tissue engineering, has announced the launch of its Series…

Grand Prix Economie Genevoise

Amal Therapeutics wins Geneva Innovation Prize

Les Grands Prix de l’économie 2023 are organised by the CCIG, with the support of the State of Geneva and…

Hybrid Brain Cell Unil and Wyss Center

A new brain cell discovered by Swiss researchers

The two major families of cells that make up the brain, neurons and glial cells, secretly hid a hybrid cell,…

100 startups

HAYA Therapeutics is Switzerland’s most promising startup

The 13th edition of the TOP 100 Swiss Startup Award celebrated Switzerland’s best startups according to a 100-person strong jury:…

Antion Biosciences

A breakthrough in the US for Antion Biosciences SA

Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, announces the granting of a significant patent…

HCK Coreline

Healthcare Konnect (HCK) and Coreline Europe GmbH start a partnership

Healthcare Konnect (HCK) and Coreline Europe GmbH start a new partnership to amplify the inherent value of diagnostic accuracy.  …

Agora Care Pristem SA

Agora Care partners with PRISTEM SA

Two Western Switzerland startups join forces to revolutionize medical imaging   Agora Care is a Geneva-based company developing a patient-centered…

UNIGE Highway Code Cell

Deciphering the “highway code” of our cells

A team from UNIGE has identified a new process governing the growth of the ‘roads’ that enable cells to thrive….

ten23health

ten23 health expands sterile manufacturing capacity at its VIVA 1® facility in Visp

ten23 health®, a global contract development and manufacturing organization, announced a capacity expansion for the manufacture of sterile drug product…

Diatheris

CHF 40,000 For Diatheris

The Geneva-based biotech startup won Venture Kick’s second stage of financial and entrepreneurial support. The project aims to achieve optimal…

Neurosoft Bioelectronics 1

First in Human Recording of Brain Activities Achieved by Neurosoft Bioelectronics

The Swiss start-up created a stretchable high-channel electrode grid that was successfully used in a first-in-human clinical study in a…

CHUV@home

CHUV@home: an application to monitor patients after surgery

Nearly 1,800 people have already used the CHUV@home application since it was launched in 2021. Patients who have undergone surgery…

Campus Santé Sion

Pôle Santé Campus in Sion – Foundation stone laid

The Pôle Santé Campus in Valais will bring together on the same site training activities in health and social work,…

Genolier Innovation Hub

Genolier Innovation Hub: an ambitious medical center

In the heart of the Swiss Health Valley, the holding company AEVIS VICTORIA SA is investing more than CHF 100…

Alzheimer UNIGE HUG

A tool for predicting the future of Alzheimer’s patients

A team from the University and the HUG has determined which imaging technique is best for early detection of the…

Venture Leaders Medtech 2023

10 medtech projects were selected to join the Swiss National Startup team that will travel to Boston and Cambridge next…

Bearmind FIT

Bearmind reaches CHF 2 million funding

The start-up develops sensors and algorithms to provide a real-time assessment of the risk of concussion for professional athletes.  …

PhenomX Health SA

An app to empower women during their menopause

PhenomX Health SA, a femtech start–up based in Biopôle, launches a wellness and precision nutrition app for menopause care in Switzerland,…

UNIGE - oncology

UNIGE scientists identified genes involved in the progression of cancer

Tissues, blood vessels, cells: tumours develop in a complex ecosystem known as the tumour microenvironment.  A team from the University…

Gaia Tech AG

Gaia Tech AG raises CHF 480,000

The Bern-based start-up extracts natural antioxidants from agricultural waste and has successfully closed its pre-seed funding round with SICTIC business angels, Venture…

Epiterna

Epiterna raised €10 Million

The longetivity start-up, based at Biopôle, is funded by Prima Materia, the investment firm founded by Spotify founder Daniel Ek and…

Swissmedic

MRA between Switzerland and the USA in the area of Good Manufacturing Practice for medicinal products takes effect

The Mutual Recognition Agreement (MRA) between Switzerland and the United States in the area of Good Manufacturing Practice for medicinal…

Medicxi

Medicxi announces a $400m fund for life sciences projects

Medicxi, a leading European life sciences investment firm, announces its $400 million Medicxi IV fund. The new fund will continue…

CHUV - heart transplant

CHUV: a child on bi-ventricular cardiac assistance could be weaned off the machine and avoid a heart transplant

After spending a year in the Pediatric Intensive Care Unit at CHUV, a 4-year-old boy did not need a heart…

Givaudan Dairy Alternatives

Givaudan expands its Protein Hub in Zurich to create dairy alternatives

Geneva-based Givaudan has expanded the Protein Hub at its flagship Zurich Innovation Centre in Kemptthal, to support the growth of dairy…

Biopôle start-up fund

Sulfiscon and biped.ai recipients of the Biopôle Start-up Fund

The fund offers up to CHF 90,000 a year, over three consecutive years, to promising life sciences ventures.    …

Perivision

PeriVision raises between CHF 0.5 and 1 Million in a Seed Round

PeriVision is utilizing the power of artificial intelligence (AI), virtual reality (VR), and cloud computing to redefine eye testing and…

HUG HIV

A patient in remission from HIV after a bone marrow transplant

The HUG and the Institut Pasteur have announced an exceptional case of HIV remission. A promising discovery.   The patient…

biped.ai

Biped wins the Prix de la canne blanche

The Swiss Central Union for the Blind (UCBA) awards projects for blind, partially sighted and deaf-blind people. Twenty-one projects were…

Magali Bischof, BioAlps' Secretary General is interviewed by Benjamin Smadja during the 13 World Chambers congress organised by CCIG Geneva. Watch the video from 18'00. 

The Swiss Health Valley Region on One TV

Magali Bischof, BioAlps’ Secretary General is interviewed by Benjamin Smadja during the 13 World Chambers congress organised by CCIG Geneva. Watch…

ten23health

ten23 health announces expansion with the launch of quality control services

ten23 health® announces the launch of “quality control” service offerings in Switzerland for release and stability testing of clinical and…

Comphya

Comphya SA launches clinical study for erectile dysfunction in Brazil

After raising CHF 850 000 in January, and starting a clinical trial in Australia, the Swiss Medtech startup launches a…

4à6 La Tour

Innovation at Hôpital de la Tour

On Thursday 1 June, the Swiss Health Valley Community was received by Hôpital de la Tour in Meyrin during a…

Le Temps - Medtech

Le Temps – Medtechs still trapped in European reform on medical devices

Medical technology companies are still grappling with the new rules on healthcare devices and diagnostics, two years after they came…

Oncolifestyle - Debiopharm

Oncolifestyle, Debiopharm’s website to empower people living with cancer

The Swiss-based biopharmaceutical company launches a new online portal to support people with cancer, with an initial focus on prostate…

Prof. Antoine Geissbuhler BioAlps President

Prof. Antoine Geissbuhler appointed Dean of UNIGE Faculty of Medicine

BioAlps President, Prof. Antoine Geissbuhler, takes a new position. He is now at the helm of UNIGE Faculty of Medicine….

CHUV Immunotherapy

CHUV launches a new cellular immunotherapy to treat acute myeloid leukemia

This subtype of cancer, which is particularly aggressive in children and frequent in adults, responds poorly to current standard treatments….

Gender Medicine

Gender medicine: Switzerland invests CHF11 million

The Swiss government is investing CHF47 million in four national research programmes: gender medicine, biodiversity, new construction techniques and crop…

Dsm-Firmenich Adare Biome

dsm-firmenich invests € 275 Million into Adare Biome

Adare Biome, a unit of Adare Pharma Solutions (CDMO), is a historic player in the development and manufacturing of postbiotic…

Fongit Coaches

FONGIT Innovation Initiation Program for Life Sciences – and Deep Tech Projects

In 2016 FONGIT, in Geneva, and EPFL Innovation Park launched the Geneus program – the first innovation initiation program –…

AC Immune

AC Immune Receives FDA Fast Track Designation for its Alzheimer’s Vaccine candidate

Lausanne-based biopharmaceutical company AC Immune SA, announced that it has received Fast Track designation from the U.S. Food and Drug…

Défi Source 2023

Défi Source 2023 rewards 6 innovative projects focusing on people and society

Over 150 innovation and healthcare players attended the presentations of the 12 finalist projects during the finale of the second…

FIT

Dewi, DNAQuraCy, naialabs and MagFlow awarded grants from FIT

The FIT, (Fondation pour l’Innovation Technologique) in canton of Vaud awarded 4 promising Swiss Health Valley projects. DNAQuraCy spun out…

Isospec Analytics

Isospec Analytics wins CHF 150’000 and Venture Kick’s 3rd round

The startup uses molecular signatures that can be used like bar codes to identify molecules, and developed a technology to…

HUG Phage

A HUG patient saved by natural viruses called bacteriophages

For the first time, a multidisciplinary team from the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE)…

EBAmed

EBAMed raises EUR 14.35 Million in Series A Funding

The Swiss Health Valley start-up develops a novel image guidance system for the non-invasive treatment of Ventricular Tachycardia through Proton…

Venture Startup Competition

>>venture>> Startup Competition: Diatheris and ZiZAN!A Biobotanica awarded

Several Swiss Health Valley projects were rewarded during the finale of the >>venture>> Startup Competition on 26 June 2023, at…

Debiopharm

Debiopharm invests $6 Million with Benchstrength in Altis Labs

Altis Labs is a Canadian computational imaging company accelerating clinical trials with artificial intelligence.   “We are thrilled to partner…

Bloom Renewables

Bloom Renewables won the Prix Sud

Le Temps, and its main partner Romande Energie, announced the Sustainable Start-Up 2023 Prize   Bloom Biorenewables, a Fribourg based…

Lunaphore

Lunaphore Technologies to get acquired by Bio-Techne

Lunaphore Technologies SA, a Vaud-based (Switzerland) life sciences company developing technology to enable spatial biology in every laboratory, announced it…

CHUV

The ERAS protocol, developed at the CHUV, receives the “Nobel Prize for Surgery”

Under the guidance of its Director General Nicolas Demartines, the CHUV was the first hospital in Switzerland to adopt the…

W. A. de Vigier Award 2023

Three Health Valley projects received a W. A. de Vigier Award

biped.ai, Gaia Technologies and Limula received a W. A. de Vigier Award, each endowed with CHF 100,000. Over 300 submitted…

University of Bern

University of Bern strengthens research cooperation around healthcare in Africa

Together with African and European partner universities, the University of Bern is developing is establishing two long-term research collaborations. These…

bNovate

bNovate Technologies raises CHF 12 Million

bNovate Technologies, a leader in rapid bacterial detection systems for water, has announced a CHF 12 million Series C funding…

Lymphatica

CHF 400’000 for Lymphatica

The FIT (Fondation pour l’Innovation Technologique) gives a Tech Growth loans of CHF 400’000 to the EPFL spin-off, allowing her…

Swiss Medtech Award

Abionic wins the Swiss Medtech Award 2023

The EPFL spin-off, founded in 2010, wins the Swiss Medtech Award 2023 valued at CHF 75,000. Abionic specialises in providing…

Regen Lab

Regen Lab partners with Dassault Systèmes Group

Regen Lab, a Swiss commercial-stage medical technology company specializing in the research, development, registration, manufacturing and commercialization of proprietary tissue…

HUG RNA Vaccine

HUG to test a promising messenger RNA vaccine against melanoma

A messenger RNA vaccine developed by Moderna, which has recently been shown to be effective against certain cases of melanoma,…

Inselspital

Swiss and American researchers reached a potential milestone in cancer therapy

Researchers from the University of Bern, Inselspital, University Hospital Bern, and the University of Connecticut have made a significant breakthrough…

Merck Biotech Development Center

Merck inaugurates its Biotech Development Centre in Corsier-sur-Vevey

German laboratory Merck invested CHF 250 million in Corsier-sur-Vevey (VD). The 15,700 m2 building will combine research and production of…

Selexis - KBI

Selexis SA and KBI Biopharma now operate as one organisation

Selexis, an EFPL startup, was founded in 2001 before being acquired by the Japanese group JSR Life Sciences. KBI Biopharma,…

Ibex™ Lonza facilit in Visp Switzerland

Lonza acquires Dutch biotech company Synaffix

The Valais-based pharmaceutical subcontractor will pay an initial €100 million, with subsequent milestone payments of up to a further €60…

Yassin Nahi GGBa

Driving Growth and Innovation: Yassin Nahi’s Insights on the Biotech Cluster in Western Switzerland

The Swiss Biotech Report 2023 recently unveiled an impressive portrait of Switzerland’s thriving biotech sector. With record revenues of CHF…

CSEM and MOMM Diagnostics

CSEM and MOMM Diagnostics partner to develop a rapid test for preeclampsia

Among the various pregnancy complications, one of the most serious and potentially life-threatening conditions is preeclampsia affecting 3 to 8%…

Virus Grippe

How the flu virus hacks our cells

A UNIGE team has discovered how the influenza A virus hijacks the mechanism for importing iron into cells to invade…

Impossible Materials

Impossible Materials wins CHF 150,000

After raising CHF 3.8 Million last month, the Fribourg-based startup won the third and final stage of the Venture Kick…

Artiria Medical

Artiria receives FDA 510(k) Clearance for its deflectable guidewire for surgery

Artiria Medical, a Vaud-based neurovascular MedTech company, announces that its real-time deflectable guidewire has been granted the 510(k) clearance by…

Onward

A paraplegic controls his movements with his mind

Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL and CEA/CHUGA/UGA report in the journal Nature that they have re-established communication between the brain…

De Vigier Award

6 life sciences startups in the Top 10 of the W. A. de Vigier Award

From a record number of over 300 submitted projects, the jury picked their Top 10. On 20 June 2023, up…

FIF May 2023

Fluosphera SA, Kylys Aesthetics SA and Consulto supported by FONGIT

Fongit, the Fondation Genevoise pour l’Innovation Technologique, has awarded two Seed loans of 100,000 CHF to Fluosphera SA and Kylys…

WS Digital Health

Western Switzerland cantons sign an agreement on digital health

Fribourg, Geneva, Jura, Valais and Vaud are aiming to establish a legal basis for the provision and operation of other…

Onward

Onward Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury

New lead is purpose-designed to optimize the delivery of ONWARD ARC Therapy™   ONWARD Medical, a medical technology company working…

Innovators and Investors Connect

Investors et Innovators Connect

On 2 May 2023, BioAlps and Intuitive Surgical co-organised an Investors et Innovators Connect event. Our association scouted projects in…

SAKK HUG

CHF 1 Million for a clinical study on Lymphoma

Dr Noémie Lang, oncologist at Geneva University Hospital (HUG), wins the prestigious Swiss Group for Clinical Cancer Research (SAKK) Trial…

BIND

BIND: Bioinnovation Day Awards

On 11 May 2023, 31 early stage life sciences projects were presented to the public at the AGORA (Fondation ISREC)…

New Biologix

NewBiologix is betting on the industrialization of gene therapy

With CHF 45 million raised, the start-up NewBiologix, officially launched on 11 May 2023 at the Biopôle in Epalinges, has…

Novostia

Novostia raises € 2.5 Million

Novostia SA is a clinical stage company developing a breakthrough artificial heart valve.   Founded in April 2017, in Neuchâtel,…

Swiss Health Valley Photo

BioAlps 20th General Assembly

Collaboration is key to foster innovation in the Swiss Health Valley   Founded in 2003, BioAlps empowers the Swiss Health…

Gnubiotics

Nobel Laureate Prof. James Rothman and Drug Discovery Expert Dr. John Baldoni join Gnubiotics as Senior Advisors

The Swiss company has been able to recreate the unique diversity of glycan structures found in breast milk, nature’s perfect…

HCK

HealthCare Konnect and Ligence Partners to Expand Access to AI-based Echocardiography Solution

The two companies join forces to bring AI-based echocardiography solution, Ligence Heart, in Switzerland and North Africa (Morocco, Algeria, Tunisia…

Domo Health + SAK

Domo Health partners with SAK to bring advanced digital health solutions at home

SAK (St. Gallisch-Appenzellische Kraftwerke AG) has acquired a participation in Domo Health as part of a round of capital raising….

Innosuisse Swiss Accelerator

Innosuisse grants CHF 2.5 M to 7 Swiss Health Valley Life Sciences Startups

Within the framework of the Swiss Accelerator, Innosuisse supports 53 innovation projects by SMEs and startups and grants each of…

Limula

Limula SA receives CHF 2.5 million from Innosuisse Swiss Accelerator

Limula SA receives CHF 2.5 million in non-dilutive funding to accelerate the industrialisation of a closed, automated, and modular solution…

machineMD

machineMD wins Innovation World Cup 2023

machineMD, a Bern-based medtech company, was awarded the top prize at the prestigious Innovation World Cup® 2023, hosted during the…

Siegfried

Siegfried expands and invests CHF 25 million in Evionnaz (VS)

The biomanufacturing company invests of up to CHF 25 million in Valais (Switzerland) for a new global R&D Center for…

SBA report

Biotech companies thrive in Switzerland

Swiss Biotech Report 2023 shows sector weathers global disruption well and continues to play a leading role driving global healthcare…

Impossible Materials

Impossible Materials raises CHF 3,4 Million

Suspected of causing cancer, titanium dioxide, a white colouring agent, has been banned from food in Switzerland and Europe since…

Prof. George Coukos

George Coukos honored by the American Association for Cancer (AACR)

George Coukos, full professor at the Faculty of Biology and Medicine of UNIL, director of the Department of Oncology UNIL-CHUV…

Distalmotion

Distalmotion raises $ 150M

The fundraise, led by Revival Healthcare Capital, will be used to get a Food and Drug Administration (FDA) approval for…

Senior Man and Music

Music practice keeps the brain from ageing

A study led by the UNIGE, HES-SO Geneva, and EPFL revealed that music practice and active listening could prevent working…

Nagi Bioscience's team

SydLab One by Nagi Bioscience hits the market

Nagi Bioscience releases an end-to-end automated device to screen drugs, chemicals and others substances on micro-organisms.   Swiss EPFL spin-off…

Euresearch

Horizon Europe for Swiss Researchers

Swiss entities can participate in most Horizon Europe calls. Funding is provided by the Swiss government as long as Switzerland…

Biopôle - LICR

Ludwig Cancer Research and Canton of Vaud Partner to Build a Research Centre

The new centre will be dedicated to synthetic immunotherapy and immune engineering on the Biopôle site in Epalinges.   The…

Wyss Center CEO

Erwin Böttinger is the new Wyss Center Geneva CEO

The Executive Board of the Wyss Center for Bio and Neuroengineering, a non-profit research center, is pleased to announce the…

Ibex™ Lonza facilit in Visp Switzerland

Lonza completed its latest drug manufacturing line in Visp

The new line will support customers with a range of drug product manufacturing needs for both clinical and commercial supply….

De Vigier Awards

W.A. de Vigier Awards 2023: 7 Western Switzerland Life Sciences Startups Selected

15 startups were selected among 300 projects. 5 of them are set to win CHF 100,000. The Award Ceremony is…

Obesity Center CHUV

An Obesity Center opens at the CHUV

The creation of an Obesity Center at the CHUV enables the teams of Dr. Lucie Favre, head of the Obesity…

Alithea Genomics

Alithea Genomics receives CHF 500,000 from FIT

The EPFL spin-off is active in high-throughput RNA sequencing, used to examine gene expression and discover new biomarkers and drugs….

Lunaphore

Lunaphore raises CHF 40 million in Series D1 funding

The Swiss startup plans to use the funding to strengthen its growing portfolio offering in spatial biology.     Lunaphore…

OramaVR

A VR training programme for medical students supported by Innosuisse

Viva VOsCE is a revolutionary project aiming at transforming medical education through harnessing the power of Virtual Reality (VR) technology….

FIF 2023

Three new projects financed in Geneva by the FIF

Plair, Endotelix and Dr Beat Walpoth received funding from the Fongit Innovation Fund (FIF).   Plair SA: Growth loan of…

Senbiosys

Senbiosys raises more than CHF 600,000 on kickstarter

Senbiosys developed a smart ring and an application to give users inputs about their health and wellness. The EPFL spin-off…

Tech4Eva 2023

Tech4Eva selected 16 projects for its 2023 programme

16 projects have been selected for the 2023 programme   Tech4Eva is an EPFL Innovation Park and Groupe Mutuel initiative…

Debiopharm Innovation Fund

Debiopharm and Merck invest in artificial intelligence

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and M Ventures, the strategic, corporate venture capital…

Medyria

EFI-Lake Geneva Ventures and Yellowstone Holding AG invest CHF 3,5 million in Medyria

Medyria’s PyCath aims to be the only device on the market with pressure and blood flow velocity sensing for the…

Sophia Genetics / Agilent

SOPHiA GENETICS and Agilent Partner

SOPHiA GENETICS, a Lausanne-based cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with…

GeNeuro

GeNeuro raises €25 million for its treatment against long COVID

GeNeuro develops timelimab, an antibody that showed promising results in treating inflammatory symptoms for long COVID patients   GeNeuro, a…

DayOne Tech Jura

Three Jura start-ups awarded with the DayOne Tech accelerator prize 

The Jura branch of the Swiss Innovation Park Basel Area is home to 28 companies and institutions, including ten in…

Debiopharm

Debiopharm expands its oncology pipeline

The Lausanne-based biotech company has obtained global rights from a Novo Nordisk molecule and plans to take the compound forward…

Raphaël Conz

Raphaël Conz is the New Head of Department for Economic Promotion and Innovation in the canton of Vaud

Raphaël Conz is also BioAlps’ vice-president. For many years, he has worked to promote the attractiveness and the reputation of…

Medistri

Medistri invests CHF 8 million in Domdidier

The largest independent sterilisation company in Europe invests to expand its plant in Domdidier, in the canton of Fribourg.  …

Oculis

Oculis Announces US public listing on Nasdaq

A Swiss Health Valley success story! Oculis goes public.   Oculis Holding AG (“Oculis”), based at EPFL Innovation Park in…

Comphya

Comphya receives approval for first pilot clinical trial in Australia

A swissmade neuromodulator to treat erectile dysfunction starts clinical trials in Australia   Comphya SA, developer of the first neuromodulator…

Fluosphera

FluoSphera Secures a Pre-Seed Investment of $ 1M 

The US accelerator IndieBio New York which is part of SOSV, Swiss-based Mountain Labs, and EFI Lake Geneva Ventures participated…

Lunaphore

Lunaphore and CRO Sirona Dx collaborate to expand COMET™ offerings to US-based biotech and biopharma customers

Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore’s flagship COMET™ spatial biology platform as a service….

Fondation Leenaards

Leenaards Foundation 2023 Science Prizes

Leenaards Foundation announces three winners of the 2023 Science Prizes. CHF 1.5 million are awarded to support biomedical research in…

Obseva

ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland

In financial trouble, the Geneva-based femtech company had to lay off its employees and reorganize its management   Obseva, in…

Terapet

Terapet raises CHF 2,3 million

The Swiss MedTech company is developing next generation imaging technology, and closed a Pre-Series A investment round. This funding supports…

MimiX - Precomb

mimiX Biotherapeutics and PreComb join forces to fight cancer

 The two companies are partnering to accelerate the process of personalized cancer drug profiling leveraging the potential of both company’s…

Mindmaze

Izar by Mindmaze, a new smart device to improve hand rehabilitation

MindMaze, a global pioneer in the development of AI-driven digital neurotherapeutics, is proud to announce the US and EU launch…

Future of Health

7 digital health start-ups selected by the Future of Health Grant

CSS and EPFL announce the 2nd cohort of the Future of Health Program   The Future of Health Grant (FoHG)…

SEED BIOSCIENCE

SEED Biosciences teams up with Molecular Device to market its DispenCell

Biopôle-based SEED Biosciences teams up with Molecular Devices, LLC. The American leading provider of high-performance life science solutions is now…

MintWorld

Lonza wants to encourage careers In Life Sciences and opens MINTWorld

Faced with a shortage of qualified personnel in the field of mathematics, computer science, natural sciences and technology (MINT) in…

Gene Predictis

Gene Predictis is bought by NIMGenetics

The EPFL-based start-up accepted the offer of the Spanish company. The amount of the transaction has not been disclosed.  …

Sofia Genetics

SOPHiA GENETICS Expands Partnership with AstraZeneca

The Swiss start-up, specialised in AI assisted medicine, and the Swedish-British pharmaceutical company want to create multimodal approaches for cancer drug…

13 Biotech to watch

13 biotech companies to watch according to BioAlps and Labiotech.eu

BioAlps recently collaborated with Labiotech.eu to detect the 13 biotech and healthtech companies in the Swiss Health Valley to watch…

Hopital La Tour

La Tour invests CHF 750 million in a health campus in Meyrin

Hôpital de La Tour in Geneva sells its premises to finance an ambitious innovation-oriented health campus   The owners of…

AC Immune MJFOX

CHF 500 000 for AC Immune

Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Target ALS Foundation (Target ALS) provide more than USD 500,000 in…

Aspivix

Aspivix receives U.S. FDA Clearance for Carevix™, Their Novel Cervical Stabilizer

Carevix™, a novel atraumatic cervical stabilizer created by the Swiss startup ASPIVIX SA, received 510(k) clearance from the U.S. Food…

Biopôle Startup Fund winners 2022

Volumina Medical, Parithera and PeriVision win the Biopôle Startup Fund 2022

The initiative, which includes up to CHF 90,000 of support per year for up to three consecutive years, is designed…

CSEM + LIMULA

Limula and CSEM partner to automate the production of CAR T cells

A Health Valley partnership to revolutionize cancer therapies and to bring a personalised treatment for cancer patients   CSEM supports…

Calciscon

€2M Eurostars funding for a project led by Calciscon

CALCISCON, AMSTERDAM UNIVERSITY MEDICAL CENTERS and ADMESY have signed a collaborative agreement for the development of a laboratory benchtop analyzer…

Xsensio

Xsensio announces an agreement with Mayo Clinic

Xsensio Announces Know-How and Stock Purchase Agreement with Mayo Clinic   Xsensio, a Vaud-Based company that is developing the Lab-on-Skin©…

CaverSTIM

Comphya raises CHF 850 000 in a convertible loan

Comphya SA, developer of the first neuromodulator to treat erectile dysfunction (ED), announced the fundraising of CHF 850k in a…

Pills ©maksim goncharenok

Research is less profitable for the pharmaceutical industry

According to a Deloitte study, investing in research is less and less interesting. The audit and consulting firm used figures…

Ibex™ Lonza facilit in Visp Switzerland

Lonza invested CHF 1 billion in Visp in 2022

The biopharmaceutical company employs 5,000 people in Valais, and also announced a 15% sales growth in 2022, representing a total…

Alithea Chuv Pamgene

CHUV, Alithea Genomics and PanGene partner to develop a pan-cancer blood test

The three partners secured a €1 million ($1.1 million) in Eurostars grant funding to develop a first of a king…

Magali Bischof Labiotech

BioAlps and the Swiss Health Valley

Listen to Magali Bischof, BioAlps Secretary General, on Beyond Biotech podcast speaking about the Swiss Health Valley and the role…

Chuv, Ludwig Institute, EPFL

CHUV, EPFL, SIB and Roche found molecules able to suppress resistance to immunotherapy

A breakthrough in the fight against cancer: researchers from EPFL, the Ludwig Institute of the CHUV, the SIB, and Roche…

HUG Center Virtual Medicine

The HUG open a Centre for Virtual Medicine

The new Centre for Virtual Medicine at the HUG is a pioneer in the use of virtual reality for clinical…

Bionomous

BIONOMOUS closes a USD 2.7 million Series A

The Swiss-based startup builds devices to automate processes in Life Science research and prepares a product rollout and expansion.  …

machineMD

Virtual reality glasses used as a diagnostic tool for brain disorders

MachineMD, a spin-off of Inselspital Bern, and CSEM, are collaborating to diagnose brain diseases by analyzing eye movements with a…

Neurosoft Bioelectronics

Neurosoft Bioelectronics receives ISO Certification for its Quality Management System

Neurosoft Bioelectronics SA, a startup developing implantable brain-computer interfaces, announces that it has received ISO 13485:2016 Certification by TÜV SÜD…

Bachem

A CHF 1 billion contract for Bachem Group

The contract covers the delivery of a large volume of peptides over a five-year period from 2025-2029, and follows the…

Ypsomed Innovation Award 2022 – The Winners

machineMD (1st place), Pace Locator (2nd place) and Compact Motion (3rd place). The Innovation Award, worth a total of CHF…

MPC Therapeutics

A CHF 1.5M seed-funding round for MPC Therapeutics to improve CAR-T cancer therapies

MPC Therapeutics (MPC Tx), is a Swiss biotechnology company based in Geneva, focusing on metabolism and cellular rejuvenation.   The…

ten23 health

Swissfillon becomes ten23 health

ten23 health®, a global contract development and manufacturing organization (CDMO) announces the change in branding of its in Visp, Switzerland…

Stalicla

STALICLA signs exclusive in-licensing agreement with Novartis for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment

The transaction with Novartis reinforces STALICLA’s position as the leading developer of precision medicines for neurodevelopmental disorders and heralds the…

mimiX biotherapeutics Ltd

mimiX biotherapeutics launches a funding round to accelerate clinical translation of FastSkin®

mimiX biotherapeutics launches a funding round to accelerate clinical translation of FastSkin® MIMIX BIOTHERAPEUTICS LTD, a Swiss medical technology company…

Resistell

Resistell AG closes its series B first tranche of CHF 8.5 Million

Resistell provides information on which antibiotic should be used to treat the patient, and the concentration at which it should…

iOnctura

iOnctura awarded EUR 17.5 million funding from the EIC Accelerator

Funding will support iOnctura’s clinical program for IOA-289, a first-in-class autotaxin inhibitor for the treatment of pancreatic cancer   iOnctura…

Biped

An intelligent harness to facilitate the mobility of blind people

The startup Biped created a harness equipped with 3D cameras that beeps when there is a risk of hitting an…

AMF Medical SA

AMF Medical SA bought for CHF 200 million by Tandem Diabetes Care

Tandem Diabetes Care, a global US-Based insulin delivery and diabetes technology company, announced an agreement to acquire AMF Medical SA,…

Pharma Suisse

Swiss research: the pharmaceutical industry is the leading investor in 2021

In 2021, private companies spent CHF 16.8 billion in Switzerland on in-house research and development (R&D) activities. This represents an…

The Scientist

Nanolive selected in the top 10 Innovations by The Scientist

The Scientist magazine announced its top 10 new products selected by a panel of independent judges. The Lausanne-based start-up Nanolive…

MRM Debiopharm Challenge

MRM wins the Debiopharm – La Solution – Inartis Challenge

The 7th Debiopharm-La-Solution.ch-Inartis Challenge for the Quality of Life of Patient has rewarded with a prize of CHF 25’000 the…

4à6 BioAlps

VR training for new Lonza employees

How to attract and retain talented workers in the Biotech Industry? And how to train the new recruits efficiently? Lonza…

Innosuisse 2023

Innosuisse, what changes in 2023?

As of January 2023, Innosuisse is evolving. Grants will be distributed for international projects, and the financing of start-ups will…

Alliance TT

Alliance, your partner for your Innosuisse application

You have an innovative project and are thinking of submitting an Innosuisse application? With its team of specialized advisors, Alliance…

Domo Health - Pépites

Domo Health: a digital platform for home health

Lack of resources and staff, aging population, an increase in chronic diseases: the challenges of the medical world are numerous…

Long Covid Syndrome

GeNeuro starts a clinical trials for its long COVID treatment

200 patients are recruited and will be followed in 5 Swiss hospitals participating in the study. The first results are…

Prof. Antoine Geissbuhler BioAlps President

Prof. Antoine Geissbuhler elected at the Royal Academy of Medicine of Belgium

A new mission for BioAlps’ President   Professor at the Department of Radiology and Medical Informatics of the Faculty of…

Symbios

Symbios opens a new factory in Yverdon

The 12 000 m2 facility will be ready next spring in the Y-Parc in Yverdon-les-Bains. Leader in the production of custom-made…

Volumina Medical

Volumina Medical Gets a CHF 500 000 Loan from FIT

Volumina Medical is an EPFL spin-off based in Biopôle Lausanne. The company develops a biogel that supports the repair of…

Switzerland sets to accept medical devices with FDA approval

The Federal Council is to adapt national laws so that, in addition to medical devices with an EU certificate /…

ONWARD

EUR 3.7 million for ONWARD and its partners from the European Innovation Council (EIC)

The European Innovation Council Grant has been awarded to ONWARD and its research partners, including EPFL, IICT-BAS, CEA-Leti-Clinatec, and CEAList….

Limula

Limula wins the start-up Swiss Technology Award

During the Swiss Innovation Forum on 23 November 2022 in Basel, Limula won the Inventor Award.   Two other companies…

Cern et CHUV

CERN, CHUV and THERYQ develop a revolutionary FLASH radiotherapy device to fight cancer

This FLASH radiotherapy device will use very high-energy electrons (VHEE) to treat cancers that are resistant to conventional treatments, with…

BioAlps Awards

Prof. Jocelyne Bloch and Prof. Grégoire Courtine receive the BioAlps Academia Award, and Incyte the BioAlps Industry Award.

The ceremony closed the BioAlps Networking Day on 24 November 2022 in Neuchâtel, in front of 250 key players of…

Dentsply Sirona

Dentsply Sirona wins the Vaud International Business Award

The dental products world leader employs 700 people in the canton.       Each fall, the Vaud International Business…

Obseva

ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million

The Swiss company expects the sale proceeds to resolve its current over-indebtedness position ObsEva SA, a biopharmaceutical company based in…

Opna bio

Opna Bio Raises $38M in Series A Financing

Opna Bio, an Epalinges, Switzerland and San Francisco, CA-based clinical-stage biopharmaceutical company, raised $38M in Series A funding. The round…

nicollier

Claude Nicollier steps down from his position as CSEM

The former astronaut has spent 16 years as Chairperson of the Board of Directors   Effective June 2023, Claude Nicollier…

Novigenix

Novigenix announces first closing of its $20M Series B

The company validated its approach in Colorectal Cancer (CRC) screening, and provides new molecular insights and predictive algorithms for patient…

Neuria

Neuria receives the Start-Up Innovation Prize of the Canton of Fribourg

Neuria gets CHF 30 000 to develop its digital therapy hidden in video games to help fight nutrition disorders  …

PeriVision

A CHF 1.6 million Innosuisse Grant for PeriVision

PeriVision was awarded an Innosuisse research grant together with the University Hospital Bern and ARTORG Center for Biomedical Engineering Research…

MICROCITY Neuchâtel, Land of Diagnostic

A Human lean Diagnostic programme in the canton of precision watchmaking   The historical heritage of high precision and core…

Domo Health Roche

Domo Health and Roche develop a digital health solution to detect the first signs of respiratory infections

Domo Health, a leader in digital health, announced the launch of its clinical study in collaboration with Roche Pharma Suisse…

Debiopharm Yona Link

Debiopharm leads $6M round for YonaLink to Scale Global Growth

The swiss company invests into an Israelian SaaS Platform able to collect data and to reduce clinical trial timelines and…

Neurorestore

Bone marrow neurons can be rewired to enable paraplegics to walk

Jocelyne Bloch and Grégoire Courtine, two Swiss researchers, have identified a group of nerve cells unrelated to the locomotor system…

Dr. Sacha Pierre Sidjanski

Interview Sacha Sidjanski

Dr. Sacha Pierre Sidjanski is in charge of External Relations at the Faculty of Life Sciences at EPFL. He explains…

BioAlps Incyte

🔺4à6 BioAlps at Incyte🔺

  On 22 September 2022, Jonathan Dickinson, executive vice-president at Incyte, received the Swiss Health Valley Community in Morges.  …

Novochizol Alpha Chitin

Novochizol SA and Alpha Chitin Partner to Produce a Chitosan-Based Polysaccharide

Alpha Chitin will manufacture both Novochizol™ raw materials and Novochizol™-based intermediate products.   Alpha Chitin, a French biobased chemistry company…

Sofia Genetics Microsft

SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis

The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDM™ health data analysis platform available with Microsoft Azure…

CSEM Dixi Polytool

Dixi Polytool wins CSEM’s Digital Journey Contest

The company will receive CHF 100,000 in technical support from CSEM to develop a smart factory and a 100% autonomous…

Prof Kalia

Interview Prof. Yogeshvar Kalia

Prof. Yogeshvar Kalia is Professor at the Faculty of Pharmaceutical Sciences at the University of Geneva (UNIGE) speaks about the…

Microbiome

How does the microbiota work?

Researchers at the University of Bern and University Hospital Bern have been able to comprehensively study the bacteria of the…

HUG Endotelix

A new test to avoid miscarriages and strokes

The HUG and the Unige have found a way to better detect the antibodies that cause thrombosis, which leads to…

MedAlliance

Cordis spends 1.14 billion francs to buy MedAlliance

Nyon-based MedAlliance, a start-up active in the field of vascular medical technology, has been acquired by the American multinational Cordis…

NeSensing

Netsensing Technology finalists of the 14th Healthcare Innovation World Cup at Medica 2022

Incubated at Microcity Neuchâtel, Netsensing Technology is excited to announce that it has been selected as one of the Top12…

Denis Cavin

Interview Denis Cavin

Why is Western Switzerland is a perfect place for lifesciences companies? Listen to Denis Cavin, Economic Development Officer at State of Geneva…

Oculis

Oculis to go public

The Lausanne-based company Oculis SA, and European Biotech Acquisition Corp, announced a business combination agreement to create a Nasdaq-listed biopharmaceutical…

Sun Bioscience

SUN Bioscience receives an EPFL Alumni Awards

The two co-founders of SUN bioscience received an EPFL Alumni Award, a price that distinguishes researchers over the course of…

La Source research programme

Improving the working conditions of health care workers

Collecte d’informations pour un projet de recherche HEIG-VD / Institut et Haute Ecole de Santé La Source – Conciliation vie privée vie professionnelle – TOUTES LES SOLUTIONS DE TOUS LES SECTEURS D’ACTIVITE SONT LES BIENVENUES

Firmenich

Firmenich inaugurates its new campus in Geneva

The 225,000 m2 site, located in the towns of Satigny and La Plaine, has a largely automated production capacity of…

Orama VR

ORamaVR raises 2.4M EUR in a post-seed funding round

The leader in medical virtual reality (VR) training tools, based in Geneva, provides immersive virtual reality solutions that allow the…

HealthCare Konnect

BoneView®, an AI solution to improve fractures diagnostic on X-rays images

Gleamer and HealthCare Konnect (HCK) partner to expand access to AI-Based double check-in fractures, effusions, dislocations and bone lesions on…

Ron Appel Christophe Dessimoz

Ron Appel, SIB’s president, retires

Bioinformatics pioneer gives way to the next generation   Ron Appel pioneered the field of bioinformatics in Switzerland and supported…

ArcoScreen and DAAV

ArcoScreen and DAAV are FIT

ArcoScreen and DAAV both receive a Tech Seed loan of CHF 100’000 from the Foundation for Technological Innovation (FIT). ArcoScreen…

Endometriosis

Progress in the diagnosis of endometriosis

Researchers from the University of Bern and Inselspital and University Hospital Bern, in collaboration with Australian scientists, are developing a…

Flowbone team

Flowbone SA concludes a CHF 2.1 million Seed round

The EPFL spin-off, active in the field of bone regeneration, prepares its US market entry.   “With aging population, fractures…

Unige Hepatite B

A UNIGE team reveals how Hepatitis B could be cured

The swiss🇨🇭 researchers have deciphered the precise functioning of a protective mechanism that could lead to a potential post-infection treatment…

Top 18 European Biotech startups

Four Swiss🇨🇭 start-ups in the Top 18 European TechBio companies

ONWARD, Haya Therapeutics, Retinai and Engimmune Therapeutics are in the top 18 Biotech companies in Europe according to investors. Stuck…

Volumina Medical

Volumina Medical closes its Series A funding to develop Adipearl

Clinique La Prairie and Skyviews Life Science Ltd are among the new investors   Volumina Medical, a spin-off from the…

Biopôle SA

Three new buildings on the Biopôle site in Lausanne

Biopôle SA announces a new partnership with Edmond de Rothschild Real Estate SICAV for the construction of three new buildings…

Fongit Fund

iOnctura, EBAMed and Terapet awarded by the Fongit

Fongit, the Fondation Genevoise pour l’Innovation Technologique, has just announced the latest beneficiaries of the Fongit Innovation Fund (FIF). iOnctura…

Future of Health Grant

Future of Health: 10 digital healthcare start-ups awarded

EPFL Innovation Park and CSS present the 2022 cohort   The Future of Health Grant programme to support innovation in…

Nanolive

Nanolive SA closes a series C round at $22.2 million

After the successful closing of a US $22.2 million Series C equity financing, Nanolive announces the appointment of two extraordinary…

Hedera Dx

Hedera Dx raises €14 million in seed funding

The Swiss companies wants to accelerate the adoption of liquid biopsies for cancer testing   Swiss techbio company Hedera Dx,…

Incepto

Incepto raised €27 million

The platform for artificial intelligence solutions applied to medical imaging, announces a €27 million round of financing. The goal: to…

Onward Arm Injury

Onward Confirms Amazing Results to restore Arm and Hand Function in People With Spinal Cord Injury

The Up-LIFT study evaluating ARC-EX Therapy demonstrated the effectiveness of the device to improve extremity strength and function in people…

A year of Swiss biological and biomedical data science: SIB Swiss Institute of Bioinformatics

Discover some of the key highlights of the national organization for biological and biomedical data science in the SIB Profile 2022, our annual activity report. Together, our infrastructure solutions, expertise and interdisciplinary collaborations foster better science and healthcare, and give Switzerland a strong voice in global issues around life science data.

Selexis - Next Immune

Selexis and NexImmune Sign an Agreement to Advance Multiple Immunotherapies Targeting Rare Cancers

This Agreement supports the development of molecules targeting acute myeloid leukemia, multiple myeloma, human papillomavirus (HPV) associated tumors, and additional…

Debiopharm Whitelab Genomics

Debiopharm Innovation Funds invests to accelerate the development of genomics medicines via technology powered AI

The strategic investment arm of Swiss biopharmaceutical company Debiopharm wants to reduce biotherapies’ development time and cost using AI (Artificial…

Top 100 startups

Top 100 Swiss Startups 2022: the Life Sciences Winners

17 Western Switzerland Life Sciences startups in biotech, medtech and foodtech were selected   The TOP 100 Swiss Startup Award 2022…

Novartis 100 million investment

Novartis invests CHF 100 million in Basel

A new state-of-the-art biologics centre   Novartis announced plans to invest around CHF 100 million in the development of next-generation…

BCC Fribourg